| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4fb056479dbbe7c81e240a0c0e90785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90391f51d2d97db351d4c10c52253fb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7661a7d6884afaa44d908744a0a115b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2105b9682ef875ab2d232684e85f8260 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-099
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2006-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25a4fa962de2a3a1cec0a4c2977ba7fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a74f9cad59117429344f724f5d9b15ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ed730b9a58eb72b6f3d4425d3013ab2 |
| publicationDate |
2006-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006109285-A1 |
| titleOfInvention |
Methods and compounds for the treatment of autoimmune diseases and chronic inflammatory conditions |
| abstract |
Described is a method for modulating an immune response in order to treat conditions such as autoimmune disease. Specifically it has been shown that the adoptive transfer of dendritic cells primed with filamentous haemagglutinin can serve to prevent the onset and development of EAE, a murine model for multiple sclerosis. Such a finding can be used to provide a therapy which can be used to treat autoimmune diseases and immune-mediated disorders . |
| priorityDate |
2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |